Literature DB >> 11438840

Driven gait orthosis for improvement of locomotor training in paraplegic patients.

G Colombo1, M Wirz, V Dietz.   

Abstract

DESIGN: Single cases.
OBJECTIVE: To compare the effects of manually assisted locomotor training in paraplegic patients with the automated training by a driven gait orthosis.
SETTING: ParaCare, University Hospital Balgrist in Zurich, Switzerland.
METHODS: Treadmill training with manual assistance and by a driven gait orthosis was applied to two spinal cord injured patients. The first patient had an incomplete lesion at C3, the second a complete lesion at C5. They were selected by convenience sample. The EMG activity of the leg muscles rectus femoris, biceps femoris, gastrocnemius medials (GM) and tibialis anterior (TA) was visually compared for the two training methods. GM and TA activity was also quantified by calculating the variation ratio between the EMG of the patients and a set of healthy subjects.
RESULTS: No significant difference between the two training methods was found according to the leg muscle EMG activity.
CONCLUSION: Neuronal centers in the spinal cord become activated in a similar way by the manually assisted and the automated locomotor training. With the driven gait orthosis training sessions can be prolonged and workload of therapists can be reduced, and therefore, the automated training represents an alternative to the conventional therapy.

Entities:  

Mesh:

Year:  2001        PMID: 11438840     DOI: 10.1038/sj.sc.3101154

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  50 in total

1.  Modulation of locomotor activity in complete spinal cord injury.

Authors:  L Lünenburger; M Bolliger; D Czell; R Müller; V Dietz
Journal:  Exp Brain Res       Date:  2006-06-08       Impact factor: 1.972

2.  Increases in muscle activity produced by vibration of the thigh muscles during locomotion in chronic human spinal cord injury.

Authors:  David Cotey; T George Hornby; Keith E Gordon; Brian D Schmit
Journal:  Exp Brain Res       Date:  2009-05-29       Impact factor: 1.972

Review 3.  Influence of skill and exercise training parameters on locomotor recovery during stroke rehabilitation.

Authors:  T George Hornby; Jennifer L Moore; Linda Lovell; Elliot J Roth
Journal:  Curr Opin Neurol       Date:  2016-12       Impact factor: 5.710

4.  Role and Significance of Trunk and Upper Extremity Muscles in Walker-Assisted Paraplegic Gait: A Case Study.

Authors:  Mina Baniasad; Farzam Farahmand; Mokhtar Arazpour; Hassan Zohoor
Journal:  Top Spinal Cord Inj Rehabil       Date:  2017-06-12

Review 5.  Training to achieve over ground walking after spinal cord injury: a review of who, what, when, and how.

Authors:  Jaynie F Yang; Kristin E Musselman
Journal:  J Spinal Cord Med       Date:  2012-09       Impact factor: 1.985

Review 6.  Poststroke motor dysfunction and spasticity: novel pharmacological and physical treatment strategies.

Authors:  Stefan Hesse; Cordula Werner
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Medial gastrocnemius myoelectric control of a robotic ankle exoskeleton.

Authors:  Catherine R Kinnaird; Daniel P Ferris
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2009-02       Impact factor: 3.802

8.  Short-term locomotor adaptation to a robotic ankle exoskeleton does not alter soleus Hoffmann reflex amplitude.

Authors:  Pei-Chun Kao; Cara L Lewis; Daniel P Ferris
Journal:  J Neuroeng Rehabil       Date:  2010-07-26       Impact factor: 4.262

9.  Patient-cooperative control increases active participation of individuals with SCI during robot-aided gait training.

Authors:  Alexander Duschau-Wicke; Andrea Caprez; Robert Riener
Journal:  J Neuroeng Rehabil       Date:  2010-09-10       Impact factor: 4.262

10.  Functional reorganization of soleus H-reflex modulation during stepping after robotic-assisted step training in people with complete and incomplete spinal cord injury.

Authors:  Maria Knikou
Journal:  Exp Brain Res       Date:  2013-05-25       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.